当前位置：
X-MOL 学术
›
Ther. Adv. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia
Therapeutic Advances in Hematology ( IF 3.4 ) Pub Date : 2022-10-28 , DOI: 10.1177/20406207221132346 Nan Zhang 1 , Xiaoyan Liu 1 , Jinxian Wu 1 , Xinqi Li 1 , Qian Wang 1 , Guopeng Chen 1 , Linlu Ma 1 , Sanyun Wu 1 , Fuling Zhou 2
Therapeutic Advances in Hematology ( IF 3.4 ) Pub Date : 2022-10-28 , DOI: 10.1177/20406207221132346 Nan Zhang 1 , Xiaoyan Liu 1 , Jinxian Wu 1 , Xinqi Li 1 , Qian Wang 1 , Guopeng Chen 1 , Linlu Ma 1 , Sanyun Wu 1 , Fuling Zhou 2
Affiliation
Background:The clinical risk classification of acute myelocytic leukemia (AML) is largely based on cytogenetic and molecular genetic detection. However, the optimal treatment for intermediate-risk ...
中文翻译：
血清蛋白质组学筛选细胞间粘附分子 2 可改善急性髓性白血病的中危分层
背景：急性髓细胞性白血病（AML）的临床风险分类主要基于细胞遗传学和分子遗传学检测。然而，中等风险的最佳治疗...
更新日期：2022-10-28
中文翻译：
血清蛋白质组学筛选细胞间粘附分子 2 可改善急性髓性白血病的中危分层
背景：急性髓细胞性白血病（AML）的临床风险分类主要基于细胞遗传学和分子遗传学检测。然而，中等风险的最佳治疗...
京公网安备 11010802027423号